Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Present Data at 24th Congress of the European Hematology Association

Celyad to Present Data at 24th Congress of the European Hematology Association

Celyad Announces May 2019 Investor Conference Schedule

Celyad Announces May 2019 Investor Conference Schedule

Celyad Announces April 2019 Investor Conference Schedule

Celyad Announces April 2019 Investor Conference Schedule

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Celyad Announces February and March 2019 Investor Conference Schedule

Celyad Announces February and March 2019 Investor Conference Schedule

Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS

Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS

Celyad to Participate at Upcoming Healthcare Conferences

Celyad to Participate at Upcoming Healthcare Conferences

Celyad to present CYAD-01 solid tumor clinical updates and pre-clinical pipeline data at the 2018 SITC Annual Meeting

Celyad to present CYAD-01 solid tumor clinical updates and pre-clinical pipeline data at the 2018 SITC Annual Meeting

Celyad appoints Carri Duncan as Vice-President Corporate Development & Communications

Celyad appoints Carri Duncan as Vice-President Corporate Development & Communications